BCI
HAE icon

Brinker Capital Investments’s Haemonetics HAE Stock Holding History

Brinker Capital Investments’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,162
Closed -$1.02M – 1371
2022
Q1 		$1.02M Buy
16,162
+7,233
+81% +$393K 0.02% 788
2021
Q4 		$474K Sell
8,929
-9,323
-51% -$568K 0.01% 1073
2021
Q3 		$1.22M Hold
18,252
– – 0.02% 705
2021
Q2 		$1.22M Buy
18,252
+4,106
+29% +$291K 0.02% 758
2021
Q1 		$1.57M Buy
+14,146
New +$1.75M 0.02% 574
2020
Q1 		– Sell
-56
Closed -$6K – 484
2019
Q4 		$6K Buy
+56
New +$6.78K ﹤0.01% 615

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brinker Capital Investments's HAE Position: Q2 2022 in Review

Brinker Capital Investments sold out of Haemonetics (HAE) in Q2 2022, closing a stake of 16,162 shares — an estimated $1.02M sold.

Brinker Capital Investments first reported a position in HAE in Q4 2019 and held it in 6 quarters. The position peaked at $1.57M in Q1 2021. 241 funds tracked by Wall St. Rank hold HAE as of Q2 2022.

  • Brinker Capital Investments reported no remaining Haemonetics position as of Q2 2022 after selling out during the quarter.
  • Brinker Capital Investments sold 16,162 Haemonetics shares in Q2 2022, an estimated $1.02M.
  • Brinker Capital Investments first reported a position in Haemonetics in Q4 2019 and held it in 6 quarters.
  • Brinker Capital Investments's Haemonetics position peaked at $1.57M in Q1 2021.
  • 241 funds tracked by Wall St. Rank held Haemonetics as of Q2 2022.

Based on Brinker Capital Investments's 13F filing for Q2 2022, filed 18 Jul 2022.